Skip to main content
. 2021 Nov 30;28(4):317–323. doi: 10.11005/jbm.2021.28.4.317

Fig. 1.

Fig. 1

Trabecular bone score (TBS) percentage mean changes at month 6 after treatment with romosozumab and at month 12 after treatment with denosumab or ibandronate. Error bars represent the 95% confidence interval of the mean.